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of Bioresorbable Vascular Scaffolds in
Percutaneous Coronary Intervention
of the Left Main Coronary Artery
Giuseppe Gargiulo, MD,* Giovanni Longo, MD,* Davide Capodanno, MD, PHD,* Bruno Francaviglia, MD,*
Piera Capranzano, MD,* Corrado Tamburino, MD, PHD*yA 48-year-old woman with history of multiplepercutaneous coronary interventions andbypass grafting on the left anterior descend-
ing coronary artery presented with unstable angina.
Coronary angiography showed a patent left internal
mammary artery and de novo critical stenoses of the
mid-shaft left main and the unprotected left circum-
ﬂex coronary artery (LCX). Both lesions were treated
with 2 nonoverlapping bioresorbable vascular scaf-
folds (BVS) (Absorb, Abbott Vascular, Santa Clara,
California) 3.5  12 mm at 16 atm and 3.0  18 mm
at 12 atm, respectively. Optical coherence tomogra-
phy (OCT) conﬁrmed good expansion and apposition
of the BVS (Figure 1). A short rim of fracture was
detected in the proximal portion of the left main
BVS, which landed in healthy coronary segments
both proximally and distally. No further action was
undertaken.
Thirteen months later, the patient presented with
unstable angina. The coronary angiography showed a
critical focal restenosis of the BVS on the left main.
The OCT demonstrated a severe multilayered pattern
of neointimal proliferation with multiple areas of
light attenuation suggestive for neoatherosclerosis
(the largest one presenting with a partially disrupted
cap). The previously detected rim of fracture
was embedded in the neointimal tissue. After lesionFrom the *Division of Cardiology, Ferrarotto Hospital, University of Catania,
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was implanted in-scaffold with a good ﬁnal OCT
result (Figure 1).
Mechanisms of restenosis of metallic stents
include underexpansion, geographical missing, frac-
ture, and drug resistance (1). Assuming similar etiol-
ogies for BVS, underexpansion and geographical
missing were reasonably excluded by OCT at post-
implantation (Figure 1). A causal role of the observed
scaffold fracture (located 2.1 mm proximal to the site
of restenosis) or drug resistance cannot be excluded.
Also, the presence of neoatherosclerosis with dis-
rupted cap could have played a causing role.
Management of BVS failure is not standardized.
Balloon angioplasty or drug-eluting balloon were
excluded, given the uncertain consequences inside
a BVS with partially lost integrity as a result of
the ongoing bioresorption process (2). Therefore,
implantation of a metallic drug-eluting stent was
preferred. A zotarolimus-eluting stent was chosen
because of the previously observed failures of pacli-
taxel-, sirolimus-, and everolimus-eluting platforms.
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FIGURE 1 Case Illustration
(A to E) Coronary angiograms at baseline (A), post-BVS treatment of the LCX and the left main (B), at follow-up (C), with the white arrowhead
showing the restenosis site, and post-treatment of the left main BVS restenosis (D), with stent enhancement magniﬁcation after in-scaffold
stent implantation (E). (a to e) Selected OCT cross sections and reference longitudinal view (f) post-BVS treatment of the LCX and the left main
documenting good expansion and apposition of the scaffolds, with evidence of a short rim of fracture in the proximal portion of the left main
BVS (e). (a’ to e’) Selected OCT cross sections and reference longitudinal view (f’) at follow-up with evidence of severe focal left main in-
scaffold restenosis (c’) not involving the site of fracture (e’), with multilayered pattern of neointimal proliferation with multiple areas of light
attenuation suggestive for neoatherosclerosis (asterisk), the largest with a partially disrupted cap (white arrow). (a’’ to e’’) Selected OCT cross
sections and reference longitudinal view (f’’) after treatment of the BVS failure documenting good expansion and apposition of the newly
implanted zotarolimus-eluting stent). BVS ¼ bioresorbable vascular scaffold; LCX ¼ left circumﬂex coronary artery; OCT ¼ optical coherence
tomography.
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